Lv72
4020 积分 2024-02-10 加入
Rational design of inhibitors that bind to inactive kinase conformations
16分钟前
已完结
Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase
8小时前
已完结
Issues and progress with protein kinase inhibitors for cancer treatment
9小时前
已完结
Design and synthesis of Riluzole-Ciprofloxacin hybrids as selective MST3 inhibitors for cancer treatment
3个月前
已完结
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
3个月前
已完结
Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance
3个月前
已完结
Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinase
3个月前
已完结
Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide
3个月前
已完结
Fluorocyclopropyl-containing tacrine derivatives as potent and selective dual CDK2/CDK9 inhibitors for the treatment of colorectal cancer
3个月前
已完结
Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GIST
3个月前
已完结
皖公网安备34019202002308
